Subscribe to our press releases
Invitation to information session of ChromoGenics interim report
ChromoGenics interim report for Q2 will be presented today, Thursday 26 August. On Monday 30 August, the company will hold a digital information event where shareholders and other stakeholders are invited to participate in a Q&A.
On 30 August 19:00-20:00 CEST, the company’s newly appointed CEO Fredrik Fränding and Lars Ericsson, CFO & Head of Communications, will answer questions about the interim report, status and future plans.
The chat will be available at the company’s website ChromoGenics. Questions and answers will also be available at the website after the event for a while for those who cannot participate.
This statement has been made in a Swedish and English version. In the event of any discrepancies between the Swedish and English text, the Swedish text shall prevail.
For more information, please contact:
Chromogenics is a proptech company that produces dynamic glass for real estate. The company’s product ConverLight® Dynamic, controls indoor comfort with high daylight transmission, great view and solar heat blocking and thereby reduces cost of cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are laminated in plastic film and then laminated between glass. The plastic film is easy to transport, so long shipments of bulky glass can be avoided. ChromoGenics also offers static glass, ConverLight® Static, and the ConverLight® Energy facade glass solution. ChromoGenics’ stock was listed on Nasdaq First North Growth Market in 2017 and has supplied glass technology to several major real estate companies.
ChromoGenics originates from world-leading research at Ångströmlaboratoriet at Uppsala University. The company’s production facility in Uppsala has been partially financed with conditional loans from Energimyndigheten (Energy Authority) in Sweden. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser: firstname.lastname@example.org, 08-463 83 00.